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Background
Axonal branching is a key mechanism for the develop-
ment of neuronal circuitry providing the physical basis for
the distribution and integration of information. Two
modes of axonal branch formation can be distinguished:
1) growth cone bifurcation and 2) interstitial branching of
collaterals both of which may be studied in axon projec-
tions of dorsal root ganglion (DRG) neurons into the spi-
nal cord. Our previous studies of sensory axon trajectories
identified a cGMP signaling cascade comprising the recep-
tor guanylyl cyclase natriuretic peptide receptor 2 (Npr2)
and the cGMP-dependent protein kinase I (cGKI) criti-
cally involved in axonal bifurcation of sensory axons at
the dorsal root entry zone (DREZ) of the spinal cord.
[1,2].
Results
Analyzing the mechanism of Npr2 activation in DRG we
found that C-type natriuretic peptide (CNP) is the only
natriuretic peptide expressed in the embryonic spinal
cord. Biochemical investigations revealed a Npr2-depend-
ent increase in cGMP levels in DRG upon CNP stimula-
tion. The generation of a CNP-knockout mouse where
CNP is replaced by a lacZ expression cassette allowed the
monitoring of CNP expression. Consistent with a func-
tion as an instructive signal for the ingrowth of sensory
axons CNP starts to be expressed at E9 in the spinal cord
forming a rostro-caudal gradient as development pro-
ceeds. In transverse sections CNP was initially detected in
the entire dorsal quarter of the cord but became concen-
trated within the dorso-medial parts of the cord sparing
the roof plate at more advanced stages. Comparison of the
phenotype detected in the CNP mutant mouse with those
lacking Npr2-activity or cGKI revealed a complete overlap
in all aspects analyzed indicating that these three compo-
nents act in a cascade. CNP-deficient mice displayed the
pathfinding error, a reduced size of the dorsal funiculus,
as well as the failure of sensory axon bifurcation. Further-
more, identical errors were found in the CNPlbab mouse
which contains a single point mutation in the CNP gene.
At a functional level, the distorted axonal branching is
accompanied by reduced synaptic input, as revealed by
patch clamp recordings of second-order neurons in the
dorsal horn of the spinal cord of CNP mutants [3].
Conclusion
Hence, our data demonstrate that a cGMP signaling cas-
cade including CNP, Npr2, and cGKI is essential for
axonal bifurcation at the DREZ and influences neuronal
connectivity in the dorsal spinal cord.
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